Novartis Investigative Site

Ohtsu-city, Shiga 520-2192

0 studies enrolling now · 3 studies all time

What they study most

Cardiovascular Disease, Retinopathy of Prematurity, Retinopathy of Prematurity (ROP), Type 2 Diabetes Mellitus

Studies at this site

• Rainbow Extension Study — Completed
• RAINBOW Study: RAnibizumab Compared With Laser Therapy for the Treatment of INfants BOrn Prematurely With Retinopathy of Prematurity — Completed
• Aliskiren Trial in Type 2 Diabetes Using Cardiovascular and Renal Disease Endpoints (Core and Extension Phases) — Stopped early